Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry

Background: The tumor suppressor in lung cancer-1 (TSLC1) is a tumor-suppressor gene. We evaluated the correlation between TSLC1 expression and clinicopathological characteristics of colorectal cancer patients by comparing primary colorectal cancer and adjacent normal colorectal tissues. Methods:...

Full description

Bibliographic Details
Main Author: Mehdi Nikbakht Dastjerdi
Format: Article
Language:fas
Published: Vesnu Publications 2012-05-01
Series:مجله دانشکده پزشکی اصفهان
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/1519
id doaj-0cd15fb1d669459fbbc32b14b44f5ed6
record_format Article
spelling doaj-0cd15fb1d669459fbbc32b14b44f5ed62020-11-25T01:08:57ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2012-05-011301811020Analysis of TSLC1 Expression in Colorectal Cancer Specimens by ImmunohistochemistryMehdi Nikbakht Dastjerdi0Associate professor, Department of Anatomical Sciences and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IranBackground: The tumor suppressor in lung cancer-1 (TSLC1) is a tumor-suppressor gene. We evaluated the correlation between TSLC1 expression and clinicopathological characteristics of colorectal cancer patients by comparing primary colorectal cancer and adjacent normal colorectal tissues. Methods: TSLC1 expression was evaluated in 100 pairs of primary colorectal cancerous and corresponding normal colorectal tissues using immunohistochemical staining on paraffin-embedded sections. The correlation between immunohistochemical findings and clinicopathological factors was then investigated. Age, gender, and clinicopathological presentation of patients were also noted. Results: TSLC1 was expressed in all tissues. A 71%- down regulation of TSLC1 was colorectal cancer specimens compared to the matched normal tissues. There were statistically significant correlations between TSLC1 expression and stage, location, and lymph node metastasis. Conclusion: TSLC1 expression may be a favorable biologic marker and a useful prognostic indicator in patients with colorectal cancer. Keywords: TSLC1, Colorectal cancer, Tumor suppressor gene, Immunohistochemistryhttp://jims.mui.ac.ir/index.php/jims/article/view/1519
collection DOAJ
language fas
format Article
sources DOAJ
author Mehdi Nikbakht Dastjerdi
spellingShingle Mehdi Nikbakht Dastjerdi
Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry
مجله دانشکده پزشکی اصفهان
author_facet Mehdi Nikbakht Dastjerdi
author_sort Mehdi Nikbakht Dastjerdi
title Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry
title_short Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry
title_full Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry
title_fullStr Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry
title_full_unstemmed Analysis of TSLC1 Expression in Colorectal Cancer Specimens by Immunohistochemistry
title_sort analysis of tslc1 expression in colorectal cancer specimens by immunohistochemistry
publisher Vesnu Publications
series مجله دانشکده پزشکی اصفهان
issn 1027-7595
1735-854X
publishDate 2012-05-01
description Background: The tumor suppressor in lung cancer-1 (TSLC1) is a tumor-suppressor gene. We evaluated the correlation between TSLC1 expression and clinicopathological characteristics of colorectal cancer patients by comparing primary colorectal cancer and adjacent normal colorectal tissues. Methods: TSLC1 expression was evaluated in 100 pairs of primary colorectal cancerous and corresponding normal colorectal tissues using immunohistochemical staining on paraffin-embedded sections. The correlation between immunohistochemical findings and clinicopathological factors was then investigated. Age, gender, and clinicopathological presentation of patients were also noted. Results: TSLC1 was expressed in all tissues. A 71%- down regulation of TSLC1 was colorectal cancer specimens compared to the matched normal tissues. There were statistically significant correlations between TSLC1 expression and stage, location, and lymph node metastasis. Conclusion: TSLC1 expression may be a favorable biologic marker and a useful prognostic indicator in patients with colorectal cancer. Keywords: TSLC1, Colorectal cancer, Tumor suppressor gene, Immunohistochemistry
url http://jims.mui.ac.ir/index.php/jims/article/view/1519
work_keys_str_mv AT mehdinikbakhtdastjerdi analysisoftslc1expressionincolorectalcancerspecimensbyimmunohistochemistry
_version_ 1725180756901232640